The 12 closest competitors and alternatives to BRONCUS-B among medical devices companies — ranked by similarity to what BRONCUS-B actually does, not by market-cap band.
Subscribe to see BRONCUS-B’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.
BRONCUS-B is a medical devices company headquartered in United States. It is publicly listed (02216) with a market capitalisation of $51M.
Ranked by semantic similarity — how close each company is to BRONCUS-B by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.
Similar medical devices company
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves. Pulmonx serves emphysema patients across a broad international footprint, encompassing the United States, Europe, the Middle East, Africa, and the Asia-Pacific region. The company, which changed its name from Pulmonx to Pulmonx Corporation in December 2013, was originally incorporated in 1995 and maintains its corporate headquarters in Redwood City, California.
Similar medical devices company
Noah Medical is a medical technology company that develops robotic-assisted platforms for bronchoscopic procedures. Its Galaxy System is designed to help pulmonologists and other clinicians navigate the lungs and obtain tissue samples for diagnosing suspected lung cancer and other pulmonary conditions.
Similar medical devices company
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Similar medical devices company
Bluesail Surgical is headquartered in Shanghai, China, offering a comprehensive portfolio of innovative surgical products spanning general surgery, thoracic surgery, urology, and gynecology.
Similar medical devices company
Micro-Tech (Nanjing) Co., Ltd. is a key manufacturer and global supplier of non-vascular stents and disposable biopsy forceps. The company's primary markets span China, Europe, North America, and Oceania. Its extensive product portfolio includes specialized gastroenterology devices such as longwire and shortwire biliary stents, biopsy instruments, dilation and hemostasis products, EUS tools, nitinol stents, resection devices, retrieval systems, and related accessories. For pulmonology, offerings comprise airway stents, biopsy tools, dilation balloons, cytology brushes, retrieval devices, and additional accessories. Beyond its own product lines, Micro-Tech also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services to other medical device firms. Founded in 1999, the company is headquartered in Nanjing, China.
Similar medical devices company
3DBiopsy, Inc. operates as a medical device company that develops 3D mapping software, biopsy needles, biopsy actuators, and integrated pathology systems.
Similar medical devices company
Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS through a single small incision or natural orifice; Edge Cloud Telesurgery System; and Edge Bronchoscope Robot. The company also develops and manufactures instruments for Edge Multi-Port Endoscopic Surgical Robot and Single-Port Endoscopic Surgical Robot includes bipolar grasping forceps, bipolar separation forceps, needle holder forceps, monopolar scissors, monopolar electric hooks and other surgical tools. In addition, the company develops an non-invasive surgery by developing natural orifice surgical robots. It serves hospitals. The company sells its products through distributors. The company was formerly known as Shenzhen Jingfeng Medical Technology Co., Ltd. The company was incorporated in 2017 and is based in Shenzhen, China.
Similar medical devices company
Cryofocus Medtech (Shanghai) Co. Ltd. medical device company, which manufactures cryoablation devices. Its products are bladder cyoablation system and the endoscopic clip for anastomosis. The company was founded on March 15, 2013 and is headquartered in Shanghai, China.
Similar medical devices company
Founded in 2019 and headquartered in Shanghai, China, Ronovo Surgical is a medical technology company focused on developing digital and robotic surgical systems to address unmet clinical needs.
Healthcare
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
Similar medical devices company
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BRONCUS-Band every competitor above — in one live dashboard.
Subscribe to Xcout Intel →